Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus. (Q55034045)

16 June 2018

title

Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus. (English)

1 reference

16 June 2018

0 references

T Lohmann

1

1 reference

16 June 2018

M Hawa

2

1 reference

16 June 2018

R D Leslie

3

1 reference

16 June 2018

R Lane

4

1 reference

16 June 2018

J Picard

5

1 reference

16 June 2018

M Londei

6

1 reference

16 June 2018

language of work or name

English

0 references

publication date

1 July 2000

1 reference

16 June 2018

published in

The Lancet

1 reference

16 June 2018

volume

356

1 reference

16 June 2018

issue

9223

1 reference

16 June 2018

page(s)

31-35

1 reference

16 June 2018

Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Humoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Functional diversity of helper T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Single-step allele-specific polymerase chain reaction HLA-DQ genotyping using ARMS primers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

The clinical significance of an autoimmune response against glutamic acid decarboxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

MHC class-II molecules and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

Genetics of susceptibility and resistance to insulin-dependent diabetes in stiff-man syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902431-4

7 January 2021

10.1016/S0140-6736(00)02431-4

Identifiers

DOI

1 reference

16 June 2018

1 reference

16 June 2018